Who Paid My Doc
AMPLATZER PFO Occluder Post Approval Study
Research payments
$1,918,802
Through program year 2024, $1,918,802 in research payments was reported against AMPLATZER PFO Occluder Post Approval Study, across 866 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $206,623 | 71 |
| 2023 | Research | $950,797 | 450 |
| 2022 | Research | $365 | 6 |
| 2021 | Research | $761,018 | 339 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Gajjar Kyle, TX Named on 16 payments
- Konstantinos Boudoulas Columbus, OH Named on 16 payments
- Srinivasa Potluri Plano, TX Named on 13 payments
- Amar Patel Marietta, GA Named on 13 payments
- Kurt Jacobson Madison, WI Named on 12 payments
- Clifford Kavinsky Chicago, IL Named on 12 payments
- Tanvir Bajwa Milwaukee, WI Named on 12 payments
- David Lasorda Pittsburgh, PA Named on 12 payments
- David Thaler Boston, MA Named on 11 payments
- Barry Love New York, NY Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.